A recent American study has revealed new findings about autism. The U.S. administration released a statement highlighting results from research examining the potential causes of the condition. Officials indicated that “using Tylenol in early childhood may be linked to a higher risk of autism.”
According to sources, U.S. President Donald Trump and senior health officials noted that preliminary research points to a possible connection between Tylenol use during infancy and an increased likelihood of autism in children. The findings were disclosed to the Washington Post by four people familiar with the study.
The research suggests that children exposed to Tylenol at a very young age may have a higher risk of developing autism spectrum disorders later. Authorities are now considering measures to raise awareness among parents and caregivers about the potential risks associated with early use of this common medication.
Tylenol, widely used by families to reduce fever and relieve pain, has been standard in pediatric care for decades. The study emphasizes careful monitoring of its use in infants and calls for more comprehensive research to confirm the findings and assess safe usage guidelines.
Experts stress that the results are preliminary and do not establish a definitive cause-and-effect relationship. They encourage parents to consult healthcare providers before administering any medication to young children and to stay informed about emerging research on autism and child development.